# Iovance Biotherapeutics, Inc.: Form DEF 14A, filed Apr 28, 2025

- Company: [Iovance Biotherapeutics, Inc.](/companies/iova.md) (CIK 1425205)
- Form: DEF 14A
- Filed: 2025-04-28
- Accepted by EDGAR: Apr 28, 2025, 17:00 ET
- Period: 2025-06-10
- Accession: 0001558370-25-005702
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1425205/000155837025005702/iova-20250610xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1425205/000155837025005702/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1425205/000155837025005702/iova-20250610xdef14a.htm

Filed Apr 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-005702. Last ingested by Listed: Oct 29, 2026, 17:02 ET. No prices; not investment advice.